Back to Continuing Education

Want to buy for someone else? You can purchase a token at check out.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
To inform healthcare professionals about the two most common fungi-caused invasive diseases in critically ill and immunosuppressed patients.
Goals and Outcomes
Goals and Learning Outcomes
The overall incidence of life-threatening invasive fungal infections such as Candida and Aspergillus has increased during the past several decades because, in part, of an increasing population of immunosuppressed and critically ill patients. Patients with cancer with chemotherapy-induced neutropenia (an abnormally low number of neutrophils); transplant recipients receiving immunosuppressive therapy, such as corticosteroids or cyclosporine; patients with HIV; and patients in ICUs are at an increased risk of acquiring fungal infections. The risk of infection has increased for critically ill patients with normal immune systems, as well. Nurses and other healthcare professionals need to educate these vulnerable patients about the importance of infection-control protocols to reduce their risk of developing invasive fungal infections. Such patient education can save lives.

After taking this course, you should be able to:

  • Describe the two major risk factors for invasive Candida infections
  • Discuss three ways to prevent spread of Candida auris
  • Explain three ways invasive Aspergillus infections can be prevented

Course Termination Date: 04/02/22

Content Expiration Date: 12/31/22

Course Originally Released On: 05/01/19
Details
Course Details

Course Originally Released on : 5/1/2019

REL-ACU-0-CE390-60

Course Author

Luci Perri

MSN, MPH, RN, CIC, FAPIC

Barbara Barzoloski-O'Connor

MSN, RN, CIC

Connie C. Chettle

MS, MPH, RN

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.